Anti-cd52 antibodies
US-2017349665-A1 · Dec 7, 2017 · US
against CD52
against CD52 · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K16/2893 |
| Official title | {against CD52} |
| Display label | against CD52 |
| Total patents | 232 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 22 |
| 2016 | 25 |
| 2017 | 36 |
| 2018 | 12 |
| 2019 | 29 |
| 2020 | 20 |
| 2021 | 19 |
| 2022 | 18 |
| 2023 | 17 |
| 2024 | 20 |
| 2025 | 12 |
| 2026 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Fc variants with altered binding to FcRn
US-9803023-B2 · Oct 31, 2017 · US
Fc containing polypeptides with altered glycosylation and reduced effector function
US-9790268-B2 · Oct 17, 2017 · US
Hematologic cancer treatments
US-2017232102-A1 · Aug 17, 2017 · US
Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US-9707155-B2 · Jul 18, 2017 · US
Nanoparticle complexes of paclitaxel, bevacizumab, and albumin
US-2017196833-A1 · Jul 13, 2017 · US
Methods of Treating Autoimmune Diseases
US-2017165360-A9 · Jun 15, 2017 · US
Optimized Fc variants
US-9663582-B2 · May 30, 2017 · US
Cancer treatments
US-2017128584-A1 · May 11, 2017 · US
Cancer treatments
US-2017128585-A1 · May 11, 2017 · US
Nanoparticle complexes of paclitaxel, ofatumumab, and albumin
US-2017128588-A1 · May 11, 2017 · US
Methods and compositions for treating lupus
US-9617343-B2 · Apr 11, 2017 · US
Site-specific antibody-drug conjugation through glycoengineering
US-9580511-B2 · Feb 28, 2017 · US
OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION
US-2016347837-A1 · Dec 1, 2016 · US
OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION
US-2016347825-A1 · Dec 1, 2016 · US
Optimized fc variants
US-2016340436-A9 · Nov 24, 2016 · US
Treatment of multiple sclerosis (MS)
US-9498528-B2 · Nov 22, 2016 · US
Cancer treatments
US-2016324964-A1 · Nov 10, 2016 · US
OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION
US-2016318993-A1 · Nov 3, 2016 · US
Cancer Treatments
US-2016310610-A1 · Oct 27, 2016 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K16/2893?
- CPC C07K16/2893 is the Cooperative Patent Classification code for “against CD52.”
- How many patents are filed under CPC C07K16/2893 (against CD52)?
- Our database includes 232 publications tagged with this CPC code.
- Is patent activity under CPC C07K16/2893 growing?
- Publication counts under this code: 20 in 2024 vs 12 in 2025 (latest complete years).